PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

44 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮
Lay all publications on this page into basket
1.
Birkenfeld, A.L. & Bergman, M.*: Bodyweight loss and remission of type 2 diabetes. Lancet Diabet. Endocrinol. 13, 265-267 (2025)
2.
Hummel, S. ; Köger, M. ; Bonifacio, E. & Ziegler, A.-G.: Dysglycaemia definitions and progression to clinical type 1 diabetes in children with multiple islet autoantibodies. Lancet Diabet. Endocrinol. 13, 10-12 (2025)
3.
Rubino, F.* et al.: Definition and diagnostic criteria of clinical obesity. Lancet Diabet. Endocrinol. 13, 221-262 (2025)
4.
Stefan, N. ; Yki-Järvinen, H.* & Neuschwander-Tetri, B.A.*: Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabet. Endocrinol. 13, 134-148 (2025)
5.
Stefan, N.: Does tirzepatide treatment improve skeletal muscle composition? Lancet Diabet. Endocrinol., DOI: 10.1016/S2213-8587(25)00054-3 (2025)
6.
Bonifacio, E. ; Winkler, C. ; Achenbach, P. & Ziegler, A.-G.: Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care. Lancet Diabet. Endocrinol. 12, 376-378 (2024)
7.
Sommer, J.* et al.: Depression symptoms, wellbeing, health-related quality of life, and diabetes-related distress in novel subtypes of recent-onset diabetes in Germany: A 5-year observational follow-up study. Lancet Diabet. Endocrinol. 12, 890-903 (2024)
8.
Stefan, N. ; Schiborn, C.* ; Machann, J. ; Birkenfeld, A.L. & Schulze, M.B.*: Impact of higher BMI on cardiometabolic risk: Does height matter? Lancet Diabet. Endocrinol. 12, 514-515 (2024)
9.
von Loeffelholz, C.* & Birkenfeld, A.L.: Tight versus liberal blood-glucose control in the intensive care unit: Special considerations for patients with diabetes. Lancet Diabet. Endocrinol. 12, 277-284 (2024)
10.
Dawed, A.Y.* et al.: Pharmacogenomics of GLP-1 receptor agonists: A genome-wide analysis of observational data and large randomised controlled trials. Lancet Diabet. Endocrinol. 11, 33-41 (2023)
11.
Hummel, J.* ; Kullmann, S. ; Wagner, R.* & Heni, M.*: Glycaemic fluctuations across the menstrual cycle: Possible effect of the brain. Lancet Diabet. Endocrinol. 11, 883-884 (2023)
12.
Körner, A. ; Stein, R. & Landgraf, K.*: Beyond genetic screening-functionality-based precision medicine in monogenic obesity. Lancet Diabet. Endocrinol. 11, 143-144 (2023)
13.
Perakakis, N. et al.: Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases. Lancet Diabet. Endocrinol. 11, 675-693 (2023)
14.
Sandforth, A. et al.: Mechanisms of weight loss-induced remission in people with prediabetes: A post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS). Lancet Diabet. Endocrinol. 11, 798-810 (2023)
15.
Schön, M.* et al.: Analysis of type 2 diabetes heterogeneity with a tree-like representation: Insights from the prospective German Diabetes Study and the LURIC cohort. Lancet Diabet. Endocrinol. 12, 119-131 (2023)
16.
Stefan, N. & Schulze, M.B.*: Metabolic health and cardiometabolic risk clusters: Implications for prediction, prevention, and treatment. Lancet Diabet. Endocrinol. 11, 426-440 (2023)
17.
Stefan, N. & Schulze, M.B.*: Achieving replicable subphenotypes of adult-onset diabetes - Authors' reply. Lancet Diabet. Endocrinol. 11, 636-637 (2023)
18.
Bechmann, N.* et al.: Sexual dimorphism in COVID-19: Potential clinical and public health implications. Lancet Diabet. Endocrinol. 10, 221-230 (2022)
19.
Ghalwash, M.* et al.: Two-age islet-autoantibody screening for childhood type 1 diabetes: A prospective cohort study. Lancet Diabet. Endocrinol. 10, 589-596 (2022)
20.
Stefan, N. & Cusi, K.*: A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabet. Endocrinol. 10, 284-296 (2022)
▮◀ ◀◀ 1 ... 2 ... 3 ... ▶▶ ▶▮